Vicki Moore

| Publish Date Women undergoing breast reconstruction after mastectomy have varied goals for the procedure that may not be limited

| Publish Date In patients with localized synovial sarcoma , tumor size is associated with worse progression-free survival (PFS) and

For patients with low-risk (LR) myelodysplastic syndrome (MDS) naïve to erythropoiesis-stimulating agent (ESA) therapy, long-term study results suggest a superior and more durable clinical benefit was observed with first-line luspatercept compared with epoetin alfa (EA) treatment. Findings were presented at the ASCO Annual Meeting 2026 by Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center in Houston, Texas.

US non-small cell lung cancer (NSCLC) patients who are treated through the Veterans Health Administration (VHA) have better 3-year survival outcomes

Gao L, Zhai X, Wang N, et al. A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial Blood . Published online March 11, 2026. doi:10.1182/blood.2025030972

Inoue S, Tsuboi I, Miszczyk M, et al. Time-of-day immunotherapy administration and outcomes in advanced cancers: a systematic review and meta-analysis JAMA Netw Open . 2026;9(5):e2610815. doi:10.1001/jamanetworkopen.2026.10815

In treatment-naive patients with metastatic uveal melanoma who have HLA-A2 negativity, darovasertib plus crizotinib significantly improves

Liao F, Xu Q-x, Lin P, Feng J-q, Chen D. The association between financial toxicity and mortality in hematologic malignancies: a systematic review

With the use of oral antineoplastic therapies, adherence to treatment appears to deviate from full compliance for patients with a broad variety of tumor types and with a wide range of treatment regimens, according to a recent analysis. These study findings were reported in the journal The Oncologist.

| Publish Date Patients on Medicare Advantage plans may experience constraints in accessing oncology networks, according to research published in JAMA Network Open